Peter Bader

3.1k total citations
76 papers, 1.9k citations indexed

About

Peter Bader is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Peter Bader has authored 76 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 38 papers in Immunology and 27 papers in Oncology. Recurrent topics in Peter Bader's work include Hematopoietic Stem Cell Transplantation (43 papers), Immune Cell Function and Interaction (32 papers) and CAR-T cell therapy research (17 papers). Peter Bader is often cited by papers focused on Hematopoietic Stem Cell Transplantation (43 papers), Immune Cell Function and Interaction (32 papers) and CAR-T cell therapy research (17 papers). Peter Bader collaborates with scholars based in Germany, United States and Switzerland. Peter Bader's co-authors include Thomas Klingebiel, Ulrike Koehl, Sabine Huenecke, Jan Soerensen, Dirk Schwabe, Rupert Handgretinger, Jakob Passweg, Halvard Bönig, Torsten Tonn and Peter Lang and has published in prestigious journals such as Blood, PLoS ONE and Journal of Clinical Microbiology.

In The Last Decade

Peter Bader

72 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Bader Germany 27 1.1k 846 715 311 258 76 1.9k
Udo Holtick Germany 25 631 0.6× 728 0.9× 546 0.8× 157 0.5× 322 1.2× 87 1.9k
Carolyn A. Keever-Taylor United States 25 1.3k 1.2× 1.1k 1.2× 1.3k 1.8× 206 0.7× 228 0.9× 79 2.5k
Daria Pagliara Italy 21 685 0.6× 638 0.8× 678 0.9× 182 0.6× 352 1.4× 65 1.7k
BR Blazar United States 20 1.1k 1.0× 828 1.0× 971 1.4× 339 1.1× 196 0.8× 38 2.2k
George Carrum United States 17 714 0.7× 1.0k 1.2× 322 0.5× 188 0.6× 220 0.9× 53 1.6k
Emmanuel Clave France 28 1.9k 1.8× 1.0k 1.2× 1.9k 2.7× 532 1.7× 317 1.2× 59 3.4k
Gianmaria Borleri Italy 22 1.1k 1.0× 1.1k 1.3× 523 0.7× 106 0.3× 467 1.8× 43 2.2k
Sabine Huenecke Germany 19 711 0.7× 504 0.6× 309 0.4× 162 0.5× 143 0.6× 53 1.2k
Stephanie Schneider Germany 17 1.1k 1.1× 913 1.1× 383 0.5× 114 0.4× 140 0.5× 27 2.0k
Mauro Di Ianni Italy 23 906 0.9× 463 0.5× 632 0.9× 348 1.1× 701 2.7× 85 2.3k

Countries citing papers authored by Peter Bader

Since Specialization
Citations

This map shows the geographic impact of Peter Bader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bader more than expected).

Fields of papers citing papers by Peter Bader

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Bader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bader. The network helps show where Peter Bader may publish in the future.

Co-authorship network of co-authors of Peter Bader

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Bader. A scholar is included among the top collaborators of Peter Bader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Bader. Peter Bader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jarisch, Andrea, André Willasch, Eva Rettinger, et al.. (2025). Case report: Advanced age at transplantation and pre-emptive treatment with dupilumab in DOCK8 deficiency. Frontiers in Immunology. 15. 1507494–1507494. 1 indexed citations
2.
3.
Rettinger, Eva, Martin Hutter, Peter Bader, et al.. (2024). Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia: Results of the AML BFM Study Group. Blood. 144(Supplement 1). 3548–3548.
4.
Jarisch, Andrea, Emilia Salzmann‐Manrique, Jan Soerensen, et al.. (2023). Donor‐type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors. British Journal of Haematology. 201(6). 1159–1168.
5.
6.
Bremm, Melanie, Andrea Quaiser, Matthias Merker, et al.. (2019). Improving Clinical Manufacturing of IL-15 Activated Cytokine-Induced Killer (CIK) Cells. Frontiers in Immunology. 10. 1218–1218. 21 indexed citations
7.
Merker, Matthias, Michael T. Meister, Eva Rettinger, et al.. (2018). Haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk soft tissue sarcomas: results of a single-center prospective trial. Bone Marrow Transplantation. 53(7). 891–894. 7 indexed citations
8.
Giorgi, Ugo De, Emmanuelle Nicolas‐Virelizier, Manuela Badoglio, et al.. (2017). High-Dose Chemotherapy for Adult-Type Ovarian Granulosa Cell Tumors. International Journal of Gynecological Cancer. 27(2). 248–251. 2 indexed citations
9.
Schubert, Ralf, Alexander Steinle, Thomas Klingebiel, et al.. (2017). The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector Cells. Frontiers in Immunology. 8. 202–202. 19 indexed citations
10.
Bremm, Melanie, Sabine Huenecke, Andrea Quaiser, et al.. (2016). In-vitro influence of mycophenolate mofetil (MMF) and Ciclosporin A (CsA) on cytokine induced killer (CIK) cell immunotherapy. Journal of Translational Medicine. 14(1). 264–264. 8 indexed citations
11.
12.
Beier, Rita, André Schulz, Manfred Hönig, et al.. (2012). Long-term follow-up of children conditioned with Treosulfan: German and Austrian experience. Bone Marrow Transplantation. 48(4). 491–501. 31 indexed citations
13.
Borchers, Sylvia, Melanie Bremm, Thomas Lehrnbecher, et al.. (2012). Sequential Anti-Cytomegalovirus Response Monitoring May Allow Prediction of Cytomegalovirus Reactivation after Allogeneic Stem Cell Transplantation. PLoS ONE. 7(12). e50248–e50248. 27 indexed citations
14.
Brehm, Claudia, Sabine Huenecke, Andrea Quaiser, et al.. (2011). IL-2 Stimulated but Not Unstimulated NK Cells Induce Selective Disappearance of Peripheral Blood Cells: Concomitant Results to a Phase I/II Study. PLoS ONE. 6(11). e27351–e27351. 71 indexed citations
15.
Bremm, Melanie, Sabine Huenecke, Thomas Lehrnbecher, et al.. (2011). Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3+CD4+-ratio in severe GvHD or relapse. Journal of Immunological Methods. 373(1-2). 36–44. 17 indexed citations
16.
Koehl, Ulrike, Jan Soerensen, Peter Bader, et al.. (2008). Reconstitution of Cytomegalovirus Specific T Cells after Pediatric Allogeneic Stem Cell Transplantation: Results from a Pilot Study Using a Multi-Allele CMV Tetramer Group. Klinische Pädiatrie. 220(6). 348–352. 12 indexed citations
17.
Beck, Olaf, Ulrike Koehl, Lars Tramsen, et al.. (2008). Enumeration of functionally active anti-Aspergillus T-cells in human peripheral blood. Journal of Immunological Methods. 335(1-2). 41–45. 22 indexed citations
18.
Reinhard, Harald, Thomas Klingebiel, Peter Lang, et al.. (2006). Stem cell transplantation for polycythemia vera. Pediatric Blood & Cancer. 50(1). 124–126. 6 indexed citations
19.
Lang, Peter, T. Klingebiel, Peter Bader, et al.. (2004). Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseases. Bone Marrow Transplantation. 33(1). 25–32. 26 indexed citations
20.
Greil, Johann, Peter Bader, Peter Lang, et al.. (2003). Prophylactic ribavirin treatment prevents adenovirus infection in pediatric stem cell transplant recipients. Blood. 102(11). 44916. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Udo Holtick Breakdown of academic impact, for papers by Carolyn A. Keever-Taylor Breakdown of academic impact, for papers by Daria Pagliara Breakdown of academic impact, for papers by BR Blazar Breakdown of academic impact, for papers by George Carrum Breakdown of academic impact, for papers by Emmanuel Clave Breakdown of academic impact, for papers by Gianmaria Borleri Breakdown of academic impact, for papers by Sabine Huenecke Breakdown of academic impact, for papers by Stephanie Schneider Breakdown of academic impact, for papers by Mauro Di Ianni
Rankless by CCL
2026